| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000024377 |
| Receipt No. | R000028067 |
| Official scientific title of the study | Quality of life of the cancer patients with the target therapy induced dermatologic toxicities |
| Date of disclosure of the study information | 2016/11/01 |
| Last modified on | 2017/12/15 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Quality of life of the cancer patients with the target therapy induced dermatologic toxicities | |
| Title of the study (Brief title) | Quality of life of the cancer patients with the target therapy induced dermatologic toxicities | |
| Region |
|
|
| Condition | |||||||
| Condition | Cancer | ||||||
| Classification by specialty |
|
||||||
| Classification by malignancy | Malignancy | ||||||
| Genomic information | NO | ||||||
| Objectives | |
| Narrative objectives1 | The purpose of this study is to assess a relationship between the target therapy induced dermatologic toxicities and patients'quality of life |
| Basic objectives2 | Others |
| Basic objectives -Others | Depression and Anxiety,
The Mental Adjustment to Cancer |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Health related quality of life:EQ-5D,
DLQI(Dermatology Life Quality Index) |
| Key secondary outcomes | Depression and Anxiety: K6
The Mental Adjustment to Cancer scale (MAC) |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Patient with the target therapy induced dermatologic toxicities (CTCAE Grade 1 or more),
2)Stage and metastasis are no object, 3)Patient who is able to complete to the questionnaire in Japanese, 4)Patient aged 20 or more (no upper age limit). |
|||
| Key exclusion criteria | 1)Patient decided by primary doctor that it's difficult to participate in the research because of current severer physical pain, anxiety, or depression,
2)ECOG performance status of 3 or more, 3)Patient cognitive impairment or mental disorders. |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Kaori Yagasaki |
| Organization | Keio University |
| Division name | Faculty of Nursing and Medical Care |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo |
| TEL | 03-5363-2157 |
| yagasaki@sfc.keio.ac.jp | |
| Public contact | |
| Name of contact person | Kaori Yagasaki |
| Organization | Keio University |
| Division name | Faculty of Nursing and Medical Care |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo |
| TEL | 03-5363-2157 |
| Homepage URL | |
| yagasaki@sfc.keio.ac.jp | |
| Sponsor | |
| Institute | Faculty of Nursing and Medical Care, Keio University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | JSPS KAKENHI Grant Number
JP 15H05081 |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | JAPAN |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 慶應義塾大学病院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | Skin toxicity and quality of life |
| Other related information | Depression, Anxiety
Mental Adjustment to Cancer |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028067 |